MAKO Surgical Corp. Secures Court-Ordered Permanent Injunction Against Blue Belt Technologies, Inc.
April 04 2013 - 4:05PM
MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has
obtained an Order Granting Permanent Injunction enjoining Blue Belt
Technologies, Inc. from engaging a former MAKO employee and
requiring the destruction of all proprietary MAKO business
information in Blue Belt's possession.
On January 30, 2013, Blue Belt announced that former MAKO sales
manager Jeff Gellman had been hired as West Area Vice President of
Sales. MAKO brought an action against Blue Belt and Mr. Gellman in
the U.S. District Court of the Southern District of Florida to
enforce the non-competition agreement between MAKO and Mr. Gellman
and to prohibit the use or disclosure of MAKO's proprietary
information.
By court order dated April 4, 2013, Mr. Gellman is prohibited
from working for Blue Belt in any capacity until August 2013, and
may only work in a limited capacity thereafter until 2014.
Furthermore, both Blue Belt and Mr. Gellman have been ordered to
certify under penalty of perjury that all MAKO proprietary
information in their possession has been permanently purged. The
U.S. District Court retained jurisdiction of the matter to ensure
compliance with its order.
"MAKO is pleased with the sweeping and substantial injunctive
relief we obtained on an expedited basis," said Maurice R. Ferré,
M.D., President and Chief Executive Officer of MAKO. "We will
remain vigilant in protecting the substantial investments made in
becoming the leader in the field of robotically assisted orthopedic
surgery."
The Order for Permanent Injunction was entered contemporaneous
to a separate settlement agreement among Blue Belt, Mr. Gellman and
MAKO, which provided MAKO with the described stipulated order,
along with additional relief and future protections.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets its
RIO® Robotic-Arm Interactive Orthopedic system, with specific
applications for partial knee resurfacing and total hip
replacement, and proprietary RESTORIS® Family of Implants for
orthopedic procedures called MAKOplasty®. The RIO is a
surgeon-interactive tactile surgical platform that incorporates a
robotic arm and patient-specific visualization technology, which
enables accurate, consistently reproducible bone resection for
accurate insertion and alignment of RESTORIS implants. The
MAKOplasty solution incorporates technologies enabled by an
intellectual property portfolio including more than 300 U.S. and
foreign, owned and licensed, patents and patent applications.
Additional information can be found at www.makosurgical.com.
"MAKOplasty®," "RESTORIS®," "RIO®," as well as the "MAKO" logo,
whether standing alone or in connection with the words "MAKO
Surgical Corp." are trademarks of MAKO Surgical Corp.
CONTACT: MAKO Surgical Corp.
954-628-1706
investorrelations@makosurgical.com
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024